Arkolith/Insider Trading/CRSP/Form 4

Kasinger James R.

General Counsel and SecretaryCRISPR Therapeutics AG (CRSP) · full profile →Form 4 · filed Feb 20, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$111K
Net Open-Market Flow
-$111K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 19, 2026Sell(S)2K$52.58$111K85K
Feb 18, 2026Option exercise(M)4K——87K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 18, 2026Option exercise(M)4K——0

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-061710) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML